Phenotypic alterations in human saphenous vein culture induced by tumor necrosis factor-alpha and lipoproteins: A preliminary development of an initial atherosclerotic plaque model

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Prasongsukarn, Kriengchai ^a   Chaisri, Urai ^b   Chartburus, Peenutchanee ^c   Wetchabut, Kamolwan ^b   Benjathummarak, Surachet ^d   Khachansaksumet, Vasant ^b   Maneerat, Yaowapa ^b  

^a PRAMONGKUTKLAO HOSPITAL   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c RAJAVITHI HOSPITAL   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Atherosclerosis; LDL; Saphenous vein; TNF alpha

Indexed keywords

CELL ADHESION MOLECULE; CHOLESTEROL; ESTRADIOL; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CAPPING PHENOMENON; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FOAM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; ORGAN CULTURE; PHENOTYPE; PROTEIN EXPRESSION; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; UPREGULATION;

BOVINAE; SIMPLEXVIRUS;

ANIMALS; BIOLOGICAL MARKERS; CATTLE; CULTURE MEDIA; ESTRADIOL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LIPOPROTEINS, LDL; MALE; MODELS, BIOLOGICAL; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; SAPHENOUS VEIN; TISSUE CULTURE TECHNIQUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883502440     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-132     Document Type: Article

References (42)

1. Pathogenesis of atherosclerosis. Crowther MA, Hematology Am Soc Hematol Educ Program 2005 1 436 441
2. Inflammation and the development of atherosclerosis. Mizuno Y, Jacob RF, Mason RP, J Atheroscler Thromb 2011 18 5 351 358 10.5551/jat.7591 21427505
3. Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease. Egashira K, Circ J 2002 66 6 529 533 10.1253/circj.66.529 12074266 (Pubitemid 34733489)
4. Accumulation of LDL in rat arteries is associated with activation of tumor necrosis factor-alpha expression. Niemann-Jonsson A, Dimayuga P, Jovinge S, Calara F, Ares MP, Fredrikson GN, Nilsson J, Arterioscler Thromb Vasc Biol 2000 20 10 2205 2211 10.1161/01.ATV.20.10.2205 11031205
5. Atherosclerosis. Lusis AJ, Nature 2000 407 6801 233 241 10.1038/35025203 11001066
6. Antigen-induced immunomodulation in the pathogenesis of atherosclerosis. Milioti N, Bermudez-Fajardo A, Penichet ML, Oviedo-Orta E, Clin Dev Immunol 2008 2008 723539 18551190
7. Coronary bare metal stent implantation in homozygous LDL receptor deficient swine induces a neointimal formation pattern similar to humans. Tellez A, Krueger CG, Seifert P, Winsor-Hines D, Piedrahita C, Cheng Y, Milewski K, Aboodi MS, Yi G, McGregor JC, Crenshaw T, Reed JD, Huibregtse B, Kaluza GL, Granada JF, Atherosclerosis 2010 213 2 518 524 10.1016/j.atherosclerosis.2010. 09.021 20950808
8. Estrogens and atherosclerosis: insights from animal models and cell systems. Nofer JR, J Mol Endocrinol 2012 48 2 13 R29 10.1530/JME-11-0145 22355098
9. Tumor necrosis factor-alpha antibody eluting stents reduce vascular smooth muscle cell proliferation in saphenous vein organ culture. Javed Q, Swanson N, Vohra H, Thurston H, Gershlick AH, Exp Mol Pathol 2002 73 2 104 111 10.1006/exmp.2002.2450 12231212
10. Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties. Mekontso-Dessap A, Kirsch M, Guignambert C, Zadigue P, Adnot S, Loisance D, Eddahibi S, J Thorac Cardiovasc Surg 2006 131 3 651 658 10.1016/j.jtcvs.2005.08.048 16515919
11. Validation of an in vitro model of human saphenous vein hyperplasia. Castronuovo JJ Jr, Smith TJ, Price RM, J Vasc Surg 2002 35 1 152 157 11802147 (Pubitemid 44725784)
12. Improvement of function and morphology of tumor necrosis factor-alpha treated endothelial cells with 17-beta estradiol: a preliminary study for a feasible simple model for atherosclerosis. Suwannaprapha P, Chaisri U, Riyong D, Maneerat Y, Circ J 2005 69 6 730 738 10.1253/circj.69.730 15914954 (Pubitemid 40806114)
13. Effect of shear stress on the expression of coagulation and fibrinolytic factors in both smooth muscle and endothelial cells in a co-culture model. Helenius G, Hagvall SH, Esguerra M, Fink H, Soderberg R, Risberg B, Eur Surg Res 2008 40 4 325 332 10.1159/000118028 18303268 (Pubitemid 351704905)
14. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Hergenreider E, Heydt S, Treguer K, Boettger T, Horrevoets AJ, Zeiher AM, Scheffer MP, Frangakis AS, Yin X, Mayr M, Braun T, Urbich C, Boon RA, Dimmeler S, Nat Cell Biol 2012 14 3 249 256 10.1038/ncb2441 22327366
15. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. Li H, Freeman MW, Libby P, J Clin Invest 1995 95 1 122 133 10.1172/JCI117628 7814605
16. Scavenger receptors and modified lipoproteins: fatal attractions? Zingg JM, Ricciarelli R, Azzi A, IUBMB Life 2000 49 5 397 403 10.1080/152165400410245 10902571 (Pubitemid 30436174)
17. The ubiquitin ligase Nedd4 mediates oxidized low-density lipoprotein-induced downregulation of insulin-like growth factor-1 receptor. Higashi Y, Sukhanov S, Parthasarathy S, Delafontaine P, Am J Physiol Heart Circ Physiol 2008 295 4 1684 H1689 10.1152/ajpheart.00548.2008 18723765
18. Proteomic and transcriptomic analyses of macrophages with an increased resistance to oxidized low density lipoprotein (oxLDL)-induced cytotoxicity generated by chronic exposure to oxLDL. Conway JP, Kinter M, Mol Cell Proteomics 2005 4 10 1522 1540 10.1074/mcp.M500111-MCP200 16006650 (Pubitemid 41555477)
19. Adrenalectomy stimulates the formation of initial atherosclerotic lesions: reversal by adrenal transplantation. van der Sluis RJ, van Puijvelde GH, Van Berkel TJ, Hoekstra M, Atherosclerosis 2012 221 1 76 83 10.1016/j.atherosclerosis.2011.12.022 22236481
20. Differential expression of oxidized/native lipoprotein(a) and plasminogen in human carotid and cerebral artery plaques. Umahara T, Uchihara T, Yamada S, Hashimoto T, Akimoto J, Haraoka J, Iwamoto T, Atherosclerosis 2011 215 2 392 398 10.1016/j.atherosclerosis.2010.10.048 21300353
21. Diverse bacteria promote macrophage foam cell formation via Toll-like receptor-dependent lipid body biosynthesis. Nicolaou G, Goodall AH, Erridge C, J Atheroscler Thromb 2012 19 2 137 148 10.5551/jat.10249 22123216
22. Oxidized low density lipoprotein-induced transdifferentiation of bone marrow-derived smooth muscle-like cells into foam-like cells in vitro. Yu J, Li Y, Li M, Qu Z, Ruan Q, Int J Exp Pathol 2010 91 1 24 33 10.1111/j.1365-2613. 2009.00693.x 20096071
23. Smooth muscle-specific expression of SV40 large TAg induces SMC proliferation causing adaptive arterial remodeling. Sindermann JR, Babij P, Klink JC, Kobbert C, Plenz G, Ebbing J, Fan L, March KL, Am J Physiol Heart Circ Physiol 2002 283 6 2714 H2724 12388294
24. Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'. Charafe-Jauffret E, Tarpin C, Bardou VJ, Bertucci F, Ginestier C, Braud AC, Puig B, Geneix J, Hassoun J, Birnbaum D, Jacquemier J, Viens P, J Pathol 2004 202 3 265 273 10.1002/path.1515 14991891 (Pubitemid 38325235)
25. Tumor necrosis factor enhances low density lipoprotein oxidative modification by monocytes and endothelial cells. Maziere C, Auclair M, Maziere JC, FEBS Lett 1994 338 1 43 46 10.1016/0014-5793(94)80113-4 8307154 (Pubitemid 24047779)
26. Molecular biology of atherosclerosis. Hopkins PN, Physiol REV 2013 93 1317 1542 10.1152/physrev.00004.2012 23899566
27. The immune system in atherosclerosis. Hansson GK, Hermansson A, Nat Immunol 2011 12 3 204 212 21321594
28. Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux. Nielsen LB, Atherosclerosis 1999 143 2 229 243 10.1016/S0021-9150(99)00064-7 10217351 (Pubitemid 29166903)
29. Biological characteristics of foam cell formation in smooth muscle cells derived from bone marrow stem cells. Yan P, Xia C, Duan C, Li S, Mei Z, Int J Biol Sci 2011 7 7 937 946 21850203
30. Low density lipoprotein uptake by an endothelial-smooth muscle cell bilayer. Alexander JJ, Miguel R, Graham D, J Vasc Surg 1991 13 3 444 451 10.1067/mva.1991.26867 1999867
31. The effects of a shear flow on the uptake of LDL and acetylated LDL by an EC monoculture and an EC-SMC coculture. Niwa K, Kado T, Sakai J, Karino T, Ann Biomed Eng 2004 32 4 537 543 15117027
32. Macrophage foam cell formation with native low density lipoprotein. Kruth HS, Huang W, Ishii I, Zhang WY, J Biol Chem 2002 277 37 34573 34580 10.1074/jbc.M205059200 12118008
33. Fibrous cap formation or destruction-the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Newby A, Zaltsman AB, Cardio Vas Res 1999 41 45 360
34. Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis. Monaco C, Gregan SM, Navin TJ, Fowell BMJ, Davies AH, Feldmann M, Circulation 2009 120 2462 2469 10.1161/CIRCULATIONAHA.109.851881 19948979
35. NF-kappaB signaling mediates vascular smooth muscle endothelin type B receptor expression in resistance arteries. Zheng JP, Zhang Y, Edvinsson L, Hjalt T, Xu CB, Eur J Pharmacol 2010 637 1-3 148 154 20399772
36. Lipid-soluble smoke particles upregulate vascular smooth muscle ETB receptors via activation of mitogen-activating protein kinases and NF-kappaB pathways. Xu CB, Zheng JP, Zhang W, Zhang Y, Edvinsson L, Toxicol Sci 2008 106 2 546 555 10.1093/toxsci/kfn173 18718921
37. Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Vlahopoulos S, Boldogh I, Casola A, Brasier AR, Blood 1999 94 6 1878 1889 10477716 (Pubitemid 29430403)
38. Estrogen attenuates vascular remodeling in Lp(a) transgenic mice. Nakagami F, Nakagami H, Osako MK, Iwabayashi M, Taniyama Y, Doi T, Shimizu H, Shimamura M, Rakugi H, Morishita R, Atherosclerosis 2010 211 1 41 47 10.1016/j.atherosclerosis.2010.01.016 20138621
39. 17 beta-estradiol attenuates intimal hyperplasia and macrophage accumulation with a reduction in monocyte chemoattractant protein 1 expression in a vein graft model. Ryomoto M, Wolff RA, Tomas JJ, Miyamoto T, Hoch JR, J Vasc Surg 2002 36 3 613 621 10.1067/mva.2002.125845 12218988
40. Differences in vascular bed disease susceptibility reflect differences in gene expression response to atherogenic stimuli. Deng DX, Tsalenko A, Vailaya A, Ben-Dor A, Kundu R, Estay I, Tabibiazar R, Kincaid R, Yakhini Z, Bruhn L, Quertermous T, Circ Res 2006 98 2 200 208 10.1161/01.RES.0000200738.50997.f2 16373601
41. Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli. Deng DX, Spin JM, Tsalenko A, Vailaya A, Ben-Dor A, Yakhini Z, Tsao P, Bruhn L, Quertermous T, Arterioscler Thromb Vasc Biol 2006 26 5 1058 1065 10.1161/01.ATV.0000208185. 16371.97 16456091 (Pubitemid 43732112)
42. Animal models of atherosclerosis. Getz GS, Reardon CA, Arterioscler Thromb Vasc Biol 2012 32 5 1104 1115 10.1161/ATVBAHA.111.237693 22383700